Growth Metrics

Idexx Laboratories (IDXX) Short-term Investments (2016 - 2017)

Idexx Laboratories has reported Short-term Investments over the past 6 years, most recently at $284.3 million for Q4 2017.

  • Quarterly results put Short-term Investments at $284.3 million for Q4 2017, up 19.96% from a year ago — trailing twelve months through Dec 2017 was $284.3 million (up 19.96% YoY), and the annual figure for FY2017 was $284.3 million, up 19.96%.
  • Short-term Investments for Q4 2017 was $284.3 million at Idexx Laboratories, roughly flat from $285.1 million in the prior quarter.
  • Over the last five years, Short-term Investments for IDXX hit a ceiling of $285.1 million in Q3 2017 and a floor of $453000.0 in Q1 2014.
  • Median Short-term Investments over the past 5 years was $208.4 million (2015), compared with a mean of $145.5 million.
  • Biggest five-year swings in Short-term Investments: plummeted 90.07% in 2014 and later soared 30631.79% in 2015.
  • Idexx Laboratories' Short-term Investments stood at $1.1 million in 2013, then soared by 910.47% to $10.9 million in 2014, then soared by 1859.01% to $213.6 million in 2015, then grew by 10.94% to $236.9 million in 2016, then increased by 19.96% to $284.3 million in 2017.
  • The last three reported values for Short-term Investments were $284.3 million (Q4 2017), $285.1 million (Q3 2017), and $256.9 million (Q2 2017) per Business Quant data.